Frazier Life Sciences Management as of March 31, 2026
Portfolio Holdings for Frazier Life Sciences Management
Frazier Life Sciences Management holds 38 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals (MIRM) | 18.3 | $709M | 7.7M | 92.38 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 14.0 | $542M | 17M | 32.01 | |
| Erasca (ERAS) | 10.3 | $399M | 25M | 16.18 | |
| Bridgebio Pharma (BBIO) | 6.6 | $256M | 3.4M | 74.26 | |
| Arcutis Biotherapeutics (ARQT) | 6.0 | $233M | 9.9M | 23.56 | |
| Mbx Biosciences (MBX) | 5.1 | $199M | 6.7M | 29.85 | |
| Phathom Pharmaceuticals (PHAT) | 3.6 | $139M | 13M | 11.11 | |
| Maze Therapeatics (MAZE) | 3.5 | $136M | 4.6M | 29.85 | |
| Krystal Biotech (KRYS) | 3.2 | $124M | 481k | 258.32 | |
| Trevi Therapeutics (TRVI) | 3.1 | $119M | 9.9M | 11.93 | |
| Palvella Therapeutics Inc Ne (PVLA) | 2.8 | $110M | 882k | 124.65 | |
| Kalvista Pharmaceuticals (KALV) | 2.6 | $100M | 5.0M | 20.13 | |
| Disc Medicine (IRON) | 2.2 | $87M | 1.4M | 63.94 | |
| Cytokinetics Com New (CYTK) | 2.0 | $76M | 1.2M | 65.91 | |
| Revolution Medicines (RVMD) | 1.7 | $66M | 676k | 97.25 | |
| Dyne Therapeutics (DYN) | 1.5 | $57M | 3.2M | 18.13 | |
| Savara (SVRA) | 1.4 | $53M | 9.7M | 5.46 | |
| Tarsus Pharmaceuticals (TARS) | 1.3 | $51M | 729k | 70.15 | |
| Vor Biopharma Com New (VOR) | 1.2 | $45M | 2.5M | 17.84 | |
| Agios Pharmaceuticals (AGIO) | 1.1 | $43M | 1.3M | 33.83 | |
| BioCryst Pharmaceuticals (BCRX) | 1.0 | $38M | 4.0M | 9.52 | |
| Zai Lab Adr (ZLAB) | 0.9 | $36M | 1.9M | 18.81 | |
| Aura Biosciences (AURA) | 0.9 | $34M | 5.1M | 6.69 | |
| ACADIA Pharmaceuticals (ACAD) | 0.8 | $32M | 1.4M | 22.26 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $31M | 133k | 228.73 | |
| Lexeo Therapeutics (LXEO) | 0.7 | $25M | 4.4M | 5.74 | |
| Alkermes SHS (ALKS) | 0.6 | $25M | 701k | 35.36 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $19M | 4.9M | 3.75 | |
| Monte Rosa Therapeutics (GLUE) | 0.4 | $17M | 1.0M | 16.45 | |
| Immunocore Hldgs Ads (IMCR) | 0.4 | $15M | 485k | 30.15 | |
| Mannkind Corp Com New (MNKD) | 0.4 | $15M | 5.9M | 2.45 | |
| Valneva Se Sponsored Ads (VALN) | 0.4 | $14M | 2.3M | 6.25 | |
| Evolus (EOLS) | 0.3 | $11M | 2.6M | 4.11 | |
| Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW) | 0.3 | $10M | 500k | 20.04 | |
| Allogene Therapeutics (ALLO) | 0.2 | $9.3M | 3.8M | 2.44 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.2 | $6.1M | 4.4M | 1.38 | |
| Ibio Com New (IBIO) | 0.1 | $3.7M | 2.0M | 1.90 | |
| Xilio Therapeutics | 0.1 | $3.6M | 423k | 8.41 |
